New Method for Isolating Tumor Fluid from Ovarian Cancer
Author Information
Author(s): Haslene-Hox Hanne, Oveland Eystein, Berg Kaja C., Kolmannskog Odd, Woie Kathrine, Salvesen Helga B., Tenstad Olav, Wiig Helge
Primary Institution: Department of Biomedicine, University of Bergen, Bergen, Norway
Hypothesis
Can a centrifugation method developed for animals be used to isolate interstitial fluid from human ovarian tumors?
Conclusion
The study successfully developed a technique to isolate undiluted interstitial fluid from human ovarian tumors, revealing a rich source of potential tumor-specific proteins.
Supporting Evidence
- The isolated fluid had a protein concentration six times higher than that found in patient plasma.
- The method allowed for the measurement of interstitial fluid colloid osmotic pressure in human tumors for the first time.
- 769 proteins were identified in the isolated interstitial fluid, indicating a rich source for biomarker discovery.
- The study demonstrated that the isolated fluid was representative of interstitial fluid based on the concentration of extracellular markers.
Takeaway
Researchers found a way to get fluid from ovarian tumors that can help find new cancer markers, which could improve diagnosis and treatment.
Methodology
The study used a centrifugation method to isolate interstitial fluid from ovarian tumor samples and analyzed the protein composition using proteomics.
Potential Biases
Potential contamination from intracellular proteins during the isolation process.
Limitations
The study pooled samples from a few patients, which may limit the generalizability of the findings.
Participant Demographics
Patients with ovarian carcinoma, including various stages of the disease.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website